针对易感肺结核的四个月克洛法齐明治疗方案:一项随机临床试验
Nusrat Shafiq1, Ashok Kumar2, Vikram Vohra3
1Department of Pharmacology, Clinical Pharmacology Unit, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
The Journal of antimicrobial chemotherapy
|June 6, 2025
概括
较短的,为期16周的基于克洛法齐明的药物敏感性肺结核的治疗方案是安全的,并且不低于标准的24周治疗. 这为结核病患者提供了潜在的更快的治疗选择.
科学领域:
- 传染性疾病 传染性疾病
- 肺部医学 肺部医学
- 临床试验 临床试验
背景情况:
- 克洛法西明是一种抗菌菌药物,已知可缩短多药耐药结核病 (MDR TB) 治疗时间.
- 克洛法齐明在降低药物敏感性肺结核治疗时间方面的疗效需要进一步研究.
研究的目的:
- 评估一个基于克洛法齐明的16周治疗方案是否与对药物敏感肺结核的24周标准治疗方案不逊色.
- 评估缩短结核病治疗方案的安全性和有效性.
主要方法:
- 一个多中心的随机受控试验 (CORTAIL) 将基于克洛法齐明的16周治疗方案与标准的24周治疗方案进行了比较.
- 在干预组中,克洛法齐明在整个治疗阶段取代了乙醇.
- 主要结局是治疗结束后3个月的复发率.
主要成果:
- 标准组的复发率为1.9%,16周克洛法齐明组的复发率为3.2%,在非劣势差距内.
- 两组之间1年后复发率没有显著差异.
- 在两只手臂中,类似比例的患者在治疗结束时实现了唾液涂抹阴性和细菌学治愈.
结论:
- 基于克洛法齐明的16周治疗方案是安全的,并且不低于对药物敏感肺结核的标准24周治疗方案.
- 这种较短的疗程为结核病治疗提供了一个可行的替代方案,可能会改善患者的坚持和减少医疗负担.
相关概念视频
Pulmonary Tuberculosis V
249
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
249
Pulmonary Tuberculosis IV
212
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
212
Pulmonary Tuberculosis III
459
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
459
Pulmonary Tuberculosis II
389
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
389
Pulmonary Tuberculosis I
335
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
335
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278


